|
Volumn 16, Issue 8 Suppl, 2010, Pages
|
Will the newer oral MS agents be welcomed by managed care organizations?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOSUPPRESSIVE AGENT;
ARTICLE;
ECONOMICS;
FEE;
HEALTH INSURANCE;
HUMAN;
MULTIPLE SCLEROSIS;
ORAL DRUG ADMINISTRATION;
ORGANIZATION AND MANAGEMENT;
PATIENT COMPLIANCE;
ADMINISTRATION, ORAL;
FEES, PHARMACEUTICAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MANAGED CARE PROGRAMS;
MEDICATION ADHERENCE;
MULTIPLE SCLEROSIS;
|
EID: 78651508172
PISSN: None
EISSN: 19362692
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (12)
|
References (0)
|